/FLUI.ST
FLUI.ST Stock - Fluicell AB (publ)
Healthcare|BiotechnologySTO
$11.30+4.63%
+$0.50 (+4.63%) • Dec 23
53
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.32
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.51
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $12.43
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for FLUI.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$11.19 – $11.41
TARGET (TP)$12.99
STOP LOSS$10.40
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.72
52W High$30.00
52W Low$7.45
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.86M | $3.34M | $3.25M | $2.60M | $4.63M |
| Gross Profit | $3.76M | $1.74M | $2.59M | $1.89M | $3.65M |
| Gross Margin | 202.3% | 52.1% | 79.6% | 72.5% | 78.7% |
| Operating Income | $-15,842,000 | $-26,879,000 | $-21,727,000 | $-21,695,000 | $-17,026,000 |
| Net Income | $-15,511,000 | $-26,554,000 | $-21,487,000 | $-21,720,000 | $-18,154,000 |
| Net Margin | -834.4% | -795.5% | -660.9% | -834.7% | -391.7% |
| EPS | $-13.10 | $-1.02 | $-1.37 | $-1.76 | $-1.53 |
Company Overview
Fluicell AB (publ) provides single-cell discovery platforms for biomedicine, drug development, and bioprinting applications worldwide. The company offers BioPen PRIME and BioPen FLEX microfluidic systems for maintaining localized solution delivery in single-cell experiments, as well as enabling control of the chemical environment around single intact cells in tissue or cell cultures; and Dynaflow Resolve system, a secondary ion channel screening platform, which allows for recording of various ion channel current in patch-clamp recording configuration. The company was founded in 2012 and is based in Gothenburg, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
FLUI.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-1.04
Q4 2024
EPS Surprise History
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q1 24
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 9, 2025 | — | — | — | — |
Q4 2024 | Dec 31, 2024 | — | $-1.04 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.77 | — | — |
Q2 2024 | Jun 29, 2024 | — | $-3.42 | — | — |
Q2 2024 | May 16, 2024 | — | $-6.15 | — | — |
Q1 2024 | Jan 4, 2024 | — | $-7.43 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-5.92 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-6.92 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-5.47 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-8.35 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-4.46 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-12.61 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-9.07 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-10.76 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-9.82 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-12.33 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-11.12 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-10.21 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-11.62 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-10.26 | — | — |
Latest News
Loading news...
Frequently Asked Questions about FLUI.ST
What is FLUI.ST's current stock price?
Fluicell AB (publ) (FLUI.ST) is currently trading at $11.30 per share. The stock has moved +4.63% today.
What is the analyst price target for FLUI.ST?
No analyst price targets are currently available for this stock.
What sector is Fluicell AB (publ) in?
Fluicell AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is FLUI.ST's market cap?
Fluicell AB (publ) has a market capitalization of $0.02 billion, making it a small-cap company.
Does FLUI.ST pay dividends?
No, Fluicell AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector2CUREX.ST
2cureX AB (publ)
$0.75
Mkt Cap: $0.0B
APTA.ST
Aptahem AB (publ)
$1.12
Mkt Cap: $0.0B
CMH.ST
Chordate Medical Holding AB (publ)
$0.61
Mkt Cap: $0.0B
GUARD.ST
Guard Therapeutics International AB (publ)
$1.40
Mkt Cap: $0.0B
LIDDS.ST
LIDDS AB (publ)
$0.04
Mkt Cap: $0.0B
ODI.ST
ODI Pharma AB
$3.22
Mkt Cap: $0.1B
PROGEN.ST
Prostatype Genomics AB (publ)
$0.35
Mkt Cap: $0.0B
QUIA.ST
Quia Pharma AB (publ)
$0.00
Mkt Cap: $0.0B
SPERM.ST
Spermosens AB
$0.01
Mkt Cap: $0.0B
STABL.ST
Stayble Therapeutics AB (publ)
$0.21
Mkt Cap: $0.0B
Explore stocks similar to FLUI.ST for comparison